ReGenX AAV Vector Technology Applications

ReGenX’s proprietary technology uses adeno-associated viral (AAV) vectors for the delivery of new genetic materials to cells. AAVs, like most viruses, are uniquely designed by nature to effectively deliver genetic material to host cells.

ReGenX AAV Vector Technology has been developed through substantial investment in research and development to address the requirements of using viral vectors in vivo, with the result being platforms that are optimized and provide significant advantages over other existing methods.

Features	ReGenX AAV Vector Technology
Non-pathogenic
Non-replicating
Efficient gene delivery in vivo
Long-lasting, stable gene expression
Manufactured to high titer